Your session is about to expire
← Back to Search
Ambulation for Frailty in Lung Transplant Patients (iFRAIL Trial)
iFRAIL Trial Summary
This trial will test if a physical activity intervention is feasible and effective for improving outcomes in lung transplant patients.
iFRAIL Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowiFRAIL Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.iFRAIL Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently on a ventilator or have an ECMO cannula in place.I have had a multi-organ transplant (like liver-lung or heart-lung).I have had a lung transplant.My medical records include a complete history and physical exam.I need a machine to help me breathe during the day or night.I can walk by myself or with help from a device.I am under 18 years old.I was hospitalized before my transplant date.I am in the hospital for a fast-track transplant evaluation.I am on the waiting list for a lung transplant.I have a physical therapy consult and scored ≥6 on the JH-HLM Scale after moving to the transplant floor.
- Group 1: Ambulatory Intervention
- Group 2: No Ambulator
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What goals has this clinical trial set out to realize?
"This medical experiment, which will be monitored for one year after transplantation is conducted with the intention of reducing Hospital Length of Stay. Secondary objectives include ascertaining Accelerometer time ambulating (change in movement from pre-transplant to post-transplant), measuring Change in sarcopenia (pre and post-transplant m2) and noting Alterations in step count (difference between pre and post-transplant)."
Is the recruitment process for this clinical trial still in progress?
"The clinical trial registry registered on clinicaltrials.gov states that this particular medical study is not actively enrolling new individuals. The initial listing for the research was posted August 15th 2018 but has since been updated June 30th 2022. Nevertheless, 280 other studies are currently seeking patients to participate in their own trials."
Share this study with friends
Copy Link
Messenger